Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Biotech Angel Investors in Mexico in November 2024

Last updated: Nov 2024 A list of 15 angel investors that invest in Biotech startups based in Mexico. We rank investors based on the number of investments they made in Biotech companies from Mexico. We update this investor list every month.

Top 15 Biotech Angel Investors in Mexico in November 2024

Investor	Biotech Mexico investments
Jeff Horing	1
Jason Burke	1
Matt Cutts	1
Elizabeth Iorns	1
Ashton Kutcher	1
Dan Knox	1
Paul Buchheit	1
Bob Goodman	1
Jessica Livingston	1
Thomas James	1
Geoffrey KALISH	1
Robert Stavis	1
Mark Gormley	1
Sohail Prasad	1
Eric Urhane	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Jeff Horing has been a co-founder and managing director at Insight Venture Partners since 1995. Under his leadership Insight has become a premier venture capital and private equity firm focused on growth investments in software and internet businesses, currently investing from a $2.56 billion fund. Jeff's areas of focus include mobile,online gaming, data, infrastructure and internet software. Jeff is a former member of the board of directors of Airborne Entertainment (acquired by Cybird Co.), CTSpace (acquired by Sword Group), Beechwood Data Systems (acquired by Cap Gemini), Greenfield Online (IPO, later acquired by Microsoft), Hitwise (acquired by Experian Group Ltd), IAG Research (acquired by The Nielsen Company), ProMira Software (acquired by Manugistics), Shutterstock (IPO), SLP Infoware (acquired by Gemplus), Solarwinds Inc. (IPO NYSE: SWI), and Xchange (IPO acquired by Amdocs).Jeff is an investor or currently serves on the board of directors of AirWatch (mobile device management), Anaqua (IP asset management), GFI Software (cloud-based services), Jagex Ltd (online gaming), Nexon (online gaming), Datacore Software (storage virtualization), New Relic (application performance management), Teamviewer (remote desktop collaboration), WIX (free DIY flash-based websites), Whitney University System (distance learning technology), and Zumba (global fitness and lifestyle brand).Prior to founding Insight, Jeff was a key member of the technology investing team at Warburg Pincus. Earlier in his career he worked at Goldman Sachs in the Capital Markets group.Jeff holds an MBA from the M.I.T. Sloan School of Management. He has dual undergraduate degrees from the University of Pennsylvania’s Moore School of Engineering and Wharton School, where he graduated with high honors and was Phi Beta Kappa. Jeff is a regular speaker at Wharton as part of the Distinguished Guest speaker series.

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Series B, Series C
United States, Israel, Canada

Portfolio highlights

Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Abnormal Security — Advanced email protection to prevent credential phishing, business email compromise, account takeover, and more.
Sensi.Ai — Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care

Jason Burke is the Co-founder, Managing Director, and Investor of TBD Angels and the VP of Strategy and Business Development of Xandr. Prior to that, he was the Chief Strategy Officer for clypd, a Boston-based startup building an advertising technology platform exclusively for the TV industry and designed to empower media companies with actionablesales tools. In his role, Burke focuses on a forward-looking platform and business strategy, corporate development, partnerships, and management of clypd's strategic commercial deals.As one of the first employees at clypd, Burke spent over 3 years as VP, Product leading the product & operations teams in bringing innovative products to the $180B television advertising market. Prior to clypd, Burke spent six years building ad technology products for online video at ScanScout and Tremor Video where he had responsibility for product management, technical strategy and operations efforts.Jason is a leader with the unique experience of working with executive customer teams and internal product development/engineering groups to drive business while also solving software and implementation challenges with internal and external technical teams. He is also a frequent contributor to industry publications and participant on advertising technology and media conference presentations and panels. Jason holds several software patents focused on inventions in advertising technology and media.Jason is also an investor in early-stage companies across several verticals. He feels privileged to invest in and collaborate with talented founding teams seeking to change the world with innovative products & businesses.Jason is based in Boston and has degrees in Computer Science and Engineering Psychology from Tufts University.

Investment focus

Health Care, Information Technology, Internet
Seed, Pre-Seed, Angel
United States, Mexico

Portfolio highlights

Eva — Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks. The company's wearable device is equipped with tactile sensors which are designed to map the surface of the breast and surrounding areas, allowing women to keep a track on the changes in breast temperature, size, and weight, with the help ofbiosensors inside the cup which constantly monitors information.
Wrangle — Wrangle organizes requests in your Slack team channel. Automatically assign approvals and tasks for your team to follow up and track their status.
WorkAround — WorkAround is the accurate, scalable solution for adding human input to your data using an untapped workforce of domain experts.WorkAround's platform enables simple, quick annotation of data. Anything from classifying expenses into tax codes, annotating breast tissue to identify regions of interest, to identifying drug combinations fromclinical trial reports. We have the domain experts and a platform to facilitate a simple, secure processing of customer data and annotations.Companies that using WorkAround services not only save time and get quality service, but are also contributing to a more socially just and productive world where talent knows no boundaries, opportunity doesn’t ask for status, and work is rewarded with fair pay.

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Investment focus

SaaS, Health Care, Software
Seed, Angel, Series A
United States, Canada, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Meter Feeder — Easily pay for parking through MeterFeeder

Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.

Investment focus

Software, SaaS, Health Diagnostics
Seed
United States, Canada, Mexico

Portfolio highlights

Torch — Connect with us to put the power of trusted relationships to work. Invest in a culture of coaching, mentoring, and professional growth.
Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.

Ashton Kutcher is an actor, investor, entrepreneur, producer and philanthropist.Kutcher has been named one of TIME magazine’s “100 Most Influential People in the World,” as well as being honored by Vanity Fair ‘s “New Establishment List,” which identifies the top 50 of an innovative new breed of buccaneering visionaries, engineering prodigiesand entrepreneurs. Twice, Kutcher was named one of Forbes magazine’s “World’s Most Powerful Celebrities,” as well as one of Fast Company magazine’s “Most Creative People.”Kutcher has been investing in technology for over a decade, both as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His fund portfolio includes Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable and Affirm among others.Kutcher is also the co-founder of Thorn: Digital Defenders of Children (www.thorn.org). Thorn drives technology innovation to fight the sexual exploitation of children.Kutcher currently stars in the Netflix original series, The Ranch. He also serves as Executive Producer. Until 2015, Kutcher starred in the CBS comedy series Two and a Half Men. The show ranked as the second most-watched comedy on all of network television. Kutcher first gained recognition as Michael Kelso on the Fox series That 70’s Show, and went on to star in a variety of box office hits on the big screen – including What Happens In Vegas with Cameron Diaz, The Guardian with Kevin Costner, No Strings Attached with Natalie Portman and the cult hit Dude, Where’s My Car.Kutcher served as co-creator and producer of MTV's hit series, “Punk'd,” and The CW's reality series “Beauty and the Geek” and “True Beauty.” He has also produced films such as No Strings Attached, Killers and The Butterfly Effect. Additionally, Kutcher co-founded APlus, a digital media company devoted to spreading the message of positive journalism, a kind of storytelling that focuses on our shared humanity. In 2016, APlus was purchased by Chicken Soup for the Soul.

Investment focus

Software, E-Commerce, Apps
Seed, Series A, Series B
United States, Germany, Canada

Portfolio highlights

QD-SOL — QD-SOL uses nanoparticles to produce green hydrogen in half the time.
Spicewell — Spicewell develops and creates food seasoning products that includes various kinds of micronutrients. It uses modern science to infuse healthy and organic additions to food meals. Spicewell is based in California, USA.
HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.

Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.

Investment focus

Finance, Health Care, Crowdfunding
Seed, Funding Round
Mexico, United States

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
Character.ai — Meet AIs that feel alive. Chat with anyone, anywhere, anytime. Experience the power of super-intelligent chat bots that hear you, understand you, and remember you.
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from

Investment focus

Software, SaaS, Information Technology
Series B, Series C, Series A
United States, Mexico, Germany

Portfolio highlights

Formally — Formally is a platform for legal collaboration. We leverage intelligent technology with behavioral science to create a whole new category of legal tech. And it all starts with immigration.
Tackle — Tackle helps you identify the right buyers, co-sell with your Cloud Partners, and transact through the Marketplaces with a platform built for Cloud GTM success.
Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood

Jessica Livingston is a Co-founding partner. She is also the organizer of Startup School, the big annual startup conference, and the author of Founders at Work, a collection of interviews with successful startup founders.

Investment focus

Medical Device, Education, Health Care
Seed, Angel, Funding Round
United States, Mexico

Portfolio highlights

Balto — Balto, the sports gaming platform made for the casual, everyday fan. We’re thrilled to have you. As a quick intro, we’re Nick Montana, Spencer Cassidy and Joel Karacozoff, three individuals with a passion for gaming and an affinity for bringing people together. As driven co-founders to deliver the best experience, They have set out to create asimple, social and fun gaming interface for all.
Elpha — Elpha is where women succeed at work together. Become a member to access daily conversations with experts, insider job opportunities, and a lot of women talking candidly about work and life. Plus membership is free!
Hype and Vice — Hype and Vice combines on-trend fashion with University brands to create officially licensed college apparel women! Cool college apparel to wear for tailgates and gamedays or to lounge around your dorm.

Thomas James

Investment focus

Health Care, Biotechnology, Health Diagnostics
Seed
Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Miproto —

Mr. Kalish is a Partner at Aquiline Capital Partners. Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy from Harvard.

Investment focus

AgTech, Seafood, Biotechnology
Series A
Mexico

Portfolio highlights

Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood

Rob Stavis is a Partner at Bessemer Venture Partners.

Investment focus

Financial Services, FinTech, Finance
Series C, Series B, Series A
United States, Canada, Mexico

Portfolio highlights

Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
FLOWER CO — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
Bespoke Financial — Bespoke Financial is a licensed lender supporting cannabis companies. They alleviate working capital constraints across the entire cannabis supply chain. Bespoke supports their clients as they scale and grow with unique financing solutions and cannabis business loans.

Mark K. Gormley is a Partner at Lee Equity Partners. Prior to joining Lee Equity in 2006, Mr. Gormley was a Partner at Capital Z Financial Services Partners (“CZFS”), a leading financial services private equity firm, where he played a leading role in the operations and investment activities of the $1.85 billion fund. Mr. Gormley co-founded CZFS in1998 and shared responsibility for the oversight of all of the firm's investment and monitoring activities. Prior to founding CZFS, Mr. Gormley served as a Managing Director at Donaldson, Lufkin & Jenrette (“DLJ”), specializing in the insurance and asset management industries. While at DLJ, Mr. Gormley worked on corporate finance and merger and acquisition assignments, as well as on principal related activities on behalf of DLJ Merchant Banking. Prior to joining DLJ in 1989, he was a founding member of the Insurance Group at Merrill Lynch in 1985. Mr. Gormley serves or has served as a director of numerous public and private companies, including The Edelman Financial Group, Skopos Financial Group, Captive Resources, Carlile Bancshares, PDR Network, MidCap Financial, Universal American, Permanent General, NewStar Financial, British Marine Holdings, Catlin Group, Bank Handlowy, Ceska Sporitelna, NACOLAH among others. Mr. Gormley received a B.S.B.A. cum laude in Finance and Economics from the University of Denver and an M.B.A. from New York University.

Investment focus

Service Industry, Insurance, AgTech
Series A, Private Equity, Secondary Market
United States, Mexico

Portfolio highlights

McLarens — McLarens is an insurance industry leader providing claims management, loss adjusting and risk mitigation services to clients around the world.
Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Simplicity Group Holdings — Simplicity is the leading partner for advisors, financial institutions, and consumers by delivering the best combination of wealth accumulation and financial protection products that meet the needs of a consumer-oriented holistic financial plan.

Sohail is the Founder & CEO of Destiny (D/XYZ).Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail hasadvised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.

Investment focus

Software, Financial Services, Information Technology
Seed, Series A
United States, France, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.

Eric Urhane

Investment focus

Software, Health Care, Biotechnology
Seed, Angel
United States, Mexico, Singapore

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.

Investors by industry